Association between interleukin‐1 receptor antagonist (IL‐1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web‐based analysis

Abstract

Breast cancer is one of the leading causes of cancer mortality. Growing evidence indicates that interleukins and its polymorphisms are involved in the pathogenesis of breast cancer. Variable number of tandem repeat (VNTR) polymorphism can affect transcription rate, mRNA stability and also the resulting protein expression and activity. Hence, present study aimed to assess the possible association between interleukin-1 receptor antagonist (IL-1Ra) VNTR polymorphism, and breast cancer susceptibility in Iranian population. A total of 300 Iranian individuals, 150 breast cancer patients and 150 age-matched healthy women, were included in this study. DNA extracted by salting out method and genotyping was done using the polymerase chain reaction. The frequency of the allele 2(5% vs. 22%) and the 2/2 genotype (22% vs. 46%) of IL-1Ra VNTR polymorphism was significantly higher in healthy control compared to breast cancer patient: therefore, A2 allele may play a protective role against breast cancer and its progression (p = .0001 and OR = 0.105, 95% CI: [0.044-0.248]). The allele 2 and 2/2 genotype of the IL-Ra VNTR polymorphism can be a protective factor against breast cancer susceptibility.

Detection of IL-1β, VEGF and IL-4 with their novel genetic variations in breast cancer patients

“…In this regard, multiple studies have found a link between ovarian cancer, gastric cancer, and IL-1 gene polymorphisms ( Abbasian et al, 2018 , Raza et al, 2020 , Nahar et al, 2022 ). Additionally, numerous researches have assessed the association between BC and IL-1 gene polymorphisms ( Ibrahimi et al, 2022 , Al-Eitan et al, 2020 , Wang et al, 2019 ).…”